US Patent 7695961 Insulin related transcription factor and uses thereof
Patent 7695961 was granted and assigned to Joslin Diabetes Center (company) on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
The invention provides isolated mMafA polypeptides, nucleic acids, vectors and host cells containing them, which encode a novel insulin related transcription factor. Diagnostic methods, methods of selecting and differentiating insulin-producing cells, and methods of treatment utilizing compositions of the invention are also provided.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Arun Sharma0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07695961 Insulin related transcription factor and uses thereof US Patent 7695961 Insulin related transcription factor and uses thereof
Infobox
Patent Number
076959610
Patent Number
76959610
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076959610
Date of Patent
April 13, 2010
0Patent Application Number
118380680
Date Filed
August 13, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07695961 Insulin related transcription factor and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07695961
Date of patent
April 13, 2010
Patent application number
11838068
Date Filed
August 13, 2007
Patent primary examiner
Find more entities like US Patent 7695961 Insulin related transcription factor and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
